Preterm Birth And PROM Testing Market To Reach $3.26 Billion By 2033

Preterm Birth And PROM Testing Market Growth & Trends

The global preterm birth and PROM testing market size is estimated to reach USD 3.26 billion by 2033, expanding at a CAGR of 8.6% from 2025 to 2033, according to a new report by Grand View Research, Inc. The growing number of pregnant women, leading to an exponential rise in the number of preterm births is anticipated to drive market growth. Furthermore, the rise in the accessibility of POC will further drive the market.

Preterm births are not specific to a particular geography and have been recognized as a worldwide concern. The chance of such complication typically surges with a rising average age of pregnant women. Although over 60% of the births are found in Africa and South Asia. In lower-income nations, approximately 12% of children are born too early compared with 9% in higher-income nations. Within countries, poorer families have higher chances of premature birth. For instance, in India, many low-income states, such as Madhya Pradesh, Uttar Pradesh, and Bihar have low usage of public healthcare services for female infants. Despite the availability of free healthcare services, only around 41% of admissions to SNCUs are female infants  

In the light of COVID-19, the PROM testing market has taken a hit by disrupting the supply chain, and improper allocation of resources by companies during the ongoing pandemic affected the strategic initiatives in the market. COVID-19 infected pregnant women experienced a higher risk of developing complications such as preterm birth. Although some evidence suggests that vaccination has minimal or nearly no impact on pregnancy, however, there is no concrete research on it.  

 Request a free sample copy or view report summary: Preterm Birth And PROM Testing Market Report

Preterm Birth And PROM Testing Market Report Highlights

• By test type, the ultrasound segment held the largest revenue share, of 31.5% of the global preterm birth and PROM testing market in 2024. Since it is a traditional diagnostic procedure used for the diagnosis of preterm labor along with the fetal fibronectin test

• The preterm birth segment is projected to grow significantly in the coming years owing to huge traction of self-testing or at-home testing for PROM testing. POCT devices can be used easily and do not require any proper lab infrastructure for testing simpler target analytes in a patient's sample

• North America preterm birth and PROM testing market held the largest revenue share of 38.3% in 2024 due to the changes in lifestyle factors such as excessive alcohol consumption & sedentary lifestyles, and high prevalence of preterm births in the region.

• The Asia Pacific is projected to grow significantly in the future owing to due to the rising income disparity and poor performance of socio-economic factors. This increases the preterm births in rural areas and compels the authorities to take initiatives for increasing the accessibility of the tests

Preterm Birth And PROM Testing Market Segmentation

Grand View Research has segmented the global preterm birth and PROM testing market based on type, application, and region:

Preterm Birth And PROM Testing Type Outlook (Revenue, USD Million, 2021 - 2033)

• Pelvic Exam

• Ultrasound

• Biochemical Markers

  • Interleukin (IL)-6

  • C-Reactive Protein (CRP)

  • IL-1, IL-2, IL-8, TNF-a

  • Corticotropin-Releasing Hormone (CRH)

  • AFP (Alpha fetoprotein)

• Uterine Monitoring

• Nitazine Test

• Ferning Test

• Pooling

• PAMG-1 Immunoassay

• IGFBP Test

• Fetal Fibronectin (fFN)

• Others

Preterm Birth And PROM Testing Application Outlook (Revenue, USD Million, 2021 - 2033)

• PROM

• Preterm Labor

• Chorioamnionitis

Preterm Birth And PROM Testing Regional Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Russia

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Singapore

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Preterm Birth And PROM Testing Market

• QIAGEN

• Hologic, Inc.

• CooperSurgical Inc.

• Abbott

• Medix Biochemica

• Sera

• Laborie

• Biosynex SA

• NX Prenatal Inc.

• IQ Products